Code | 0363E | ||||
MA number | EU/1/22/1630/001 | ||||
Product Form: | con inf 1x0,5 ml/100 µg (liek.inj.skl.) | ||||
MA Status: | E - Valid centralised marketing authorisation | ||||
Type of procedure: | EU Orphan | ||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||
ATC: |
|
||||
Shelf life: | 36 | ||||
Container: | glass vial | ||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 01.04.2022 |
Validity: | 01.04.2027 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 09.05.2022 |